Eva Altmann

1.6k total citations · 1 hit paper
39 papers, 1.1k citations indexed

About

Eva Altmann is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Eva Altmann has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Eva Altmann's work include Chemical Synthesis and Analysis (11 papers), Protease and Inhibitor Mechanisms (6 papers) and Bone Metabolism and Diseases (6 papers). Eva Altmann is often cited by papers focused on Chemical Synthesis and Analysis (11 papers), Protease and Inhibitor Mechanisms (6 papers) and Bone Metabolism and Diseases (6 papers). Eva Altmann collaborates with scholars based in Switzerland, United States and Germany. Eva Altmann's co-authors include Peter Ertl, Jeffrey M. McKenna, Martin Missbach, Manfred Mutter, Jonathan A. Green, Karl‐Heinz Altmann, Leo Widler, Mira Šuša, Sandra W. Cowan‐Jacob and Sophie Racine and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Eva Altmann

37 papers receiving 1.0k citations

Hit Papers

The Most Common Functional Groups in Bioactive Molecules ... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time
    2020 265 citations Peter Ertl, Eva Altmann et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Altmann Switzerland 18 691 494 147 95 85 39 1.1k
Claudio Mapelli United States 18 594 0.9× 527 1.1× 110 0.7× 50 0.5× 57 0.7× 32 1.2k
Matthew W. D. Perry Sweden 19 834 1.2× 513 1.0× 179 1.2× 44 0.5× 147 1.7× 34 1.4k
Mark E. Schnute United States 19 618 0.9× 715 1.4× 134 0.9× 72 0.8× 44 0.5× 25 1.4k
Mark A. Ashwell United Kingdom 18 556 0.8× 423 0.9× 206 1.4× 86 0.9× 78 0.9× 39 1.2k
R. M. Garbaccio United States 22 959 1.4× 1.2k 2.4× 130 0.9× 105 1.1× 80 0.9× 40 1.9k
Jefferson Tilley United States 20 683 1.0× 563 1.1× 160 1.1× 56 0.6× 54 0.6× 64 1.4k
Marko Marjanović Croatia 20 599 0.9× 513 1.0× 182 1.2× 70 0.7× 39 0.5× 34 1.2k
Kenneth J. Barr United States 12 693 1.0× 717 1.5× 117 0.8× 80 0.8× 45 0.5× 17 1.4k
Joseph S. Warmus United States 19 448 0.6× 493 1.0× 113 0.8× 44 0.5× 75 0.9× 38 962
Sivaraman Dandapani United States 19 928 1.3× 914 1.9× 101 0.7× 136 1.4× 123 1.4× 54 1.7k

Countries citing papers authored by Eva Altmann

Since Specialization
Citations

This map shows the geographic impact of Eva Altmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Altmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Altmann more than expected).

Fields of papers citing papers by Eva Altmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Altmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Altmann. The network helps show where Eva Altmann may publish in the future.

Co-authorship network of co-authors of Eva Altmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Altmann. A scholar is included among the top collaborators of Eva Altmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Altmann. Eva Altmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez, Cristina, Elisa Iniesto, Sandra Fonseca, et al.. (2024). Hormone-mediated disassembly and inactivation of a plant E3 ubiquitin ligase complex. Cell Reports. 43(10). 114802–114802. 3 indexed citations
2.
Ertl, Peter, Eva Altmann, & Sophie Racine. (2023). The most common linkers in bioactive molecules and their bioisosteric replacement network. Bioorganic & Medicinal Chemistry. 81. 117194–117194. 19 indexed citations
3.
Ertl, Peter, et al.. (2023). Which boronic acids are used most frequently for synthesis of bioactive molecules?. Bioorganic & Medicinal Chemistry. 91. 117405–117405. 4 indexed citations
4.
Schlierf, Anita, Eva Altmann, Jean Quancard, et al.. (2016). Targeted inhibition of the COP9 signalosome for treatment of cancer. Nature Communications. 7(1). 13166–13166. 125 indexed citations
5.
Grosche, Philipp, Finton Sirockin, A. Mac Sweeney, et al.. (2014). Structure-based design and optimization of potent inhibitors of the adenoviral protease. Bioorganic & Medicinal Chemistry Letters. 25(3). 438–443. 15 indexed citations
6.
Gerspacher, Marc, Eva Altmann, Thomas Buhl, et al.. (2010). Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists). Bioorganic & Medicinal Chemistry Letters. 20(17). 5161–5164. 9 indexed citations
7.
Altmann, Eva, Reiner Aichholz, Claudia Betschart, et al.. (2007). 2-Cyano-pyrimidines:  A New Chemotype for Inhibitors of the Cysteine Protease Cathepsin K. Journal of Medicinal Chemistry. 50(4). 591–594. 23 indexed citations
8.
Altmann, Eva, Reiner Aichholz, Claudia Betschart, et al.. (2006). Dipeptide nitrile inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 16(9). 2549–2554. 19 indexed citations
9.
Altmann, Eva, Sandra W. Cowan‐Jacob, & Martin Missbach. (2004). Novel Purine Nitrile Derived Inhibitors of the Cysteine Protease Cathepsin K. Journal of Medicinal Chemistry. 47(24). 5833–5836. 52 indexed citations
10.
Altmann, Eva, Jonathan A. Green, & Marina Tintelnot‐Blomley. (2003). Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K—investigating P1′ substituents. Bioorganic & Medicinal Chemistry Letters. 13(12). 1997–2001. 16 indexed citations
11.
12.
Altmann, Eva, Johanne Renaud, Jonathan A. Green, et al.. (2002). Arylaminoethyl Amides as Novel Non-Covalent Cathepsin K Inhibitors. Journal of Medicinal Chemistry. 45(12). 2352–2354. 36 indexed citations
13.
Altmann, Eva, Martin Missbach, Jonathan A. Green, et al.. (2001). 7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters. 11(6). 853–856. 34 indexed citations
14.
Widler, Leo, Jonathan A. Green, Martin Missbach, Mira Šuša, & Eva Altmann. (2001). 7-Alkyl- and 7-Cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters. 11(6). 849–852. 43 indexed citations
15.
Missbach, Martin, Eva Altmann, Leo Widler, et al.. (2000). Substituted 5,7-diphenyl-pyrrolo[2,3 d ]pyrimidines: potent inhibitors of the tyrosine kinase c-Src. Bioorganic & Medicinal Chemistry Letters. 10(9). 945–949. 40 indexed citations
16.
Pavone, Vincenzo, Benedetto Di Blasio, Angela Lombardi, et al.. (1993). Non coded Cα,α‐disubstituted amino acids. International journal of peptide & protein research. 41(1). 15–20. 9 indexed citations
17.
Altmann, Eva, et al.. (1988). Conformational studies on host‐guest peptides containing chiral α‐methyl‐α‐amino acids. International journal of peptide & protein research. 32(5). 344–351. 30 indexed citations
18.
Altmann, Eva, Karl‐Heinz Altmann, & Manfred Mutter. (1988). Zur Synthese von (S)‐α‐Methylserin enthaltenden Peptiden. Angewandte Chemie. 100(6). 855–856. 5 indexed citations
19.
Schachinger, L., et al.. (1985). Effect of irradiation on immobilized enzymes compared with that on enzymes in solution. Radiation and Environmental Biophysics. 24(4). 259–270. 4 indexed citations
20.
Altmann, Eva. (1960). Westdeutschland unter den Gesetzen der Reproduktion des kapitals und die Arbeiterklasse. Dietz eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Mapelli Breakdown of academic impact, for papers by Matthew W. D. Perry Breakdown of academic impact, for papers by Mark E. Schnute Breakdown of academic impact, for papers by Mark A. Ashwell Breakdown of academic impact, for papers by R. M. Garbaccio Breakdown of academic impact, for papers by Jefferson Tilley Breakdown of academic impact, for papers by Marko Marjanović Breakdown of academic impact, for papers by Kenneth J. Barr Breakdown of academic impact, for papers by Joseph S. Warmus Breakdown of academic impact, for papers by Sivaraman Dandapani
Rankless by CCL
2026